PROSPECTIVE STUDY OF DEVELOPMENT OF CARDIOVASCULAR EVENTS IN RELATION WITH CARDIOVASCULAR RISK (ESSE-RF IN KEMEROVSKAYA REGION)

Aim. Evaluation of cardiovascular risk factors influence on the development of cardiovascular events (hospitalization, coronary and carotid surgery, death) in prospective study.

Material and methods. Analysis was performed by the results of multicenter epidemiologic study “Epidemiology of cardiovascular diseases and risk factors in Russian Federation (ESSE-RF)” in Kemerovskaya oblast, collected on a random sample of adult inhabitants, age 25-64 y. o. (n=1628). With the first screening, by interviewing, the data collected, on the main cardiovascular risk factors and objective data. In the prospective part of the study, in 4 years after primary screening, in participants and their families the data collected by phone interviewing, on cardiovascular events. Combinational endpoint was evaluated, by the class of cardiovascular pathology: death + hospitalization + surgery on coronary/carotid vessels. Combined influence of the studied factors was assessed with logistic regression.

Results. Among the parameters of objective study, statistically significantly influenced the probability of combination endpoint development the age (OR=1,06 in 95% CI 1,02-1,09), male gender (OR=3,79 in 95% CI 1,88-7,61); influence of anamnesis of myocardial infarction is close to significant (OR=2,43 in 95% CI 0,73-8,10). Of the questionnaire-based parameters, significant influences on the probability of combinational endpoint development depression (OR=2,38 in 95% CI 1,32-4,29). Close to significant — absence no family status (OR=1,75 in 95% CI 0,98-3,13) and decreased life quality by EUROQOL-EQ-5D (OR=1,21 in 95% CI 0,98-1,49).

Conclusion. A significant impact on the probability of cardiovascular diseases development during 4 year period of the study, do influence the age, male gender and depression.

1. Global atlas on cardiovascular disease prevention and control 2013/edited by Shanthi Mendis …[et al] WHO (In Russ.) ISBN 978-92-4 456437-0.

2. Pencina MJ, D’Agostino RB, Larson MG, et al. Predicting the Thirty-year Risk of Cardiovascular Disease: The Framingham Heart Study.Circulation. 2009; 119 (24): 307884. DOI: 10.1161/CIRCULATIONAHA.108.816694.

3. Hajifathalian K, Ueda P, Lu Y, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015; 3 (5): 339-55. DOI: 10.1016/S2213-8587(15)00081-9

4. Ueda P, Woodward M, Lu Y, et al. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. Lancet Diabetes Endocrinol. 2017; 5 (3): 196213. DOI: 10.1016/S2213-8587(17)30015-3.

5. Sarrafzadegan N, Hassannejad R, Marateb HR, et al. PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region. PLoS One. 2017; 12 (12): e0189389. DOI: 10.1371/journal.pone.0189389.

6. Wilson PW, D’Agostino R Sr, Bhatt DL, et al. An international model to predict recurrent cardiovascular disease. Am J Med. 2012; 125 (7): 695-703. e1. DOI: 10.1016/j.amjmed.2012.01.014.

7. Gafarov VV, Gromova EA, Gafarova AV, et al. Myocardial Infarction and Stress at Work Place and in the Family: 10-Year Risk of Development in an Open Population of 25-64 Year Old Men (Epidemiological Study in a Framework of the WHO Program MONICAPSYCHOSOCIAL. Kardiologija. 2011; 51 (3): 10-6. (In Russ.)

8. Halaris A. Co-morbidity between cardiovascular pathology and depression: role of inflammation. Mod Trends Pharmacopsychiatry. 2013; 28: 144-61. DOI: 10.1159/000343981.

9. Penninx BW, Beekman AT, Honig A. et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001; 58 (3): 221-7.

10. Kappert K, Bohm M, Schmieder R, at el. Impact of sex on cardiovascular outcome in patients at high cardiovascular risk. Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Pamipril Global End Point Trial (ONTARGET). Circulation. 2012. 126: 934-41. DOI: 10.1161/CIRCULATIONAHA.111.086660.

11. George J, Rapsomaniki E, Pujades-Rodriguez M, at el. How does cardiovascular disease first present in women and men? Incidence of 12 cardiovascular diseases in a contemporary cohort of 1937360 people. Circulation. 2015; 132: 1320-8. DOI: 10.1161/CIRCULATIONAHA.114.013797.

12. Boytsov SA, Samorodskaya IV. Mortality and lost years of life as a result of cardiovascular premature deaths. Cardiovascular Therapy and Prevention. 2014; 13 (2): 4-11. (In Russ.) DOI: 10.15829/17288800-2014-2-4-11